SAN ANTONIO--(BUSINESS WIRE)--Cytocentrics, Inc. has a new name ... “We are expanding our footprint in the biosciences arena,” Garvin said, “and ...
News
- Cytocentrics Becomes CytoBioscience; New Name Reflects Expanded Company Footprint in ...
- Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in ...
Puma Biotechnology, Inc. (PBYI), a biopharmaceutical company, ... at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is ...
- San Antonio Company Cytocentrics Renames Itself CytoBioscience
The name change is happening in part because the San Antonio company is expanding its footprint in bioscience, CEO James Garvin said in a press ...
- Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant ...
... were presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, Texas.
- SAT adds nonstop flight to Toronto
“Daily nonstop service to Toronto is great for San Antonio,” San Antonio ... aligning with San Antonio's top economic priorities, as part of the airport's 2016 ... is experiencing similar growth in the sectors of bioscience and new energy.